These authors contributed equally to this work.
Steatohepatitis/Metabolic Liver Disease
Glucagon-like peptide-1 receptor is present on human hepatocytes and has a direct role in decreasing hepatic steatosis in vitro by modulating elements of the insulin signaling pathway†
Article first published online: 1 FEB 2010
Copyright © 2010 American Association for the Study of Liver Diseases
Volume 51, Issue 5, pages 1584–1592, May 2010
How to Cite
Gupta, N. A., Mells, J., Dunham, R. M., Grakoui, A., Handy, J., Saxena, N. K. and Anania, F. A. (2010), Glucagon-like peptide-1 receptor is present on human hepatocytes and has a direct role in decreasing hepatic steatosis in vitro by modulating elements of the insulin signaling pathway. Hepatology, 51: 1584–1592. doi: 10.1002/hep.23569
Potential conflict of interest: Nothing to report.
- Issue published online: 22 APR 2010
- Article first published online: 1 FEB 2010
- Accepted manuscript online: 1 FEB 2010 12:00AM EST
- Manuscript Accepted: 28 DEC 2009
- Manuscript Received: 29 MAY 2009
- US Public Health Service Awards. Grant Numbers: R24 DK064399, R01 DK062092, K01 DK076742, R01 DK 075397
- EVC/CFAR Flow Cytometry Core. Grant Number: P30 A1050409
- Cancer Research Institute Investigator award
- Yerkes Research Center Base Grant. Grant Number: RR 00165
- US Public Health Service Grant. Grant Number: A1070101
Additional Supporting Information may be found in the online version of this article.
|HEP_23569_sm_suppinfofigure1A.tif||157K||Supporting Information Figure 1A|
|HEP_23569_sm_suppinfofigure1B.tif||76K||Supporting Information Figure 1B|
|HEP_23569_sm_suppinfofigure1C.tif||79K||Supporting Information Figure 1C|
Please note: Wiley Blackwell is not responsible for the content or functionality of any supporting information supplied by the authors. Any queries (other than missing content) should be directed to the corresponding author for the article.